Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3065895 | Journal of Neuroimmunology | 2006 | 4 Pages |
Abstract
Interferon-beta is a biological treatment widely used in multiple sclerosis (MS). However, not every patient responds equally well to this therapy. In this study, our aim was to evaluate the influence of a dinucleotide microsatellite located in the first intron of the interferon-gamma gene on relapse eradication in a group of interferon-beta-treated patients. Our results show a very different allelic distribution when patients with relapses were compared with relapse-free patients.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
A. MartÃnez, V. de las Heras, A. Mas Fontao, M. Bartolomé, E.G. de la Concha, E. Urcelay, R. Arroyo,